Ocugen OCGN
NASDAQ OCGN
$1.36 +0.01 (+0.74%)
At close: Sep 4, 2026 · 4:00 PM EDT

Ocugen (OCGN) Change in Accured Expenses (2014 - 2026)

Ocugen's (OCGN) quarterly Change in Accured Expenses came in at -$5.4 million in Q1 2026, down 65.18% YoY from -$15.5 million in Q1 2025, and down 547.6% on a QoQ basis from $1.2 million in Q4 2025.

Analysis

Ocugen (OCGN) Change in Accured Expenses (2014 - 2026) Analysis & Trends

Ocugen (OCGN) has 13 years of Change in Accured Expenses data on file, last reported at -$5.4 million in Q1 2026.

  • Quarterly Change in Accured Expenses fell 65.18% year-over-year to -$5.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (down 48.98% YoY) and the FY2025 annual result came in at $3.3 million, down 19.97% from the prior year.
  • Change in Accured Expenses declined to -$5.4 million in Q1 2026, from $1.2 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $3.9 million in Q3 2022 to a low of -$5.4 million in Q1 2026.
  • A 5-year average of -$47411.8 and a median of $1.2 million in 2025 frame the typical range for Change in Accured Expenses.
  • Annual changes were most pronounced in 2022 — Change in Accured Expenses soared 380.45% — and 2023, when it sank 3889.31%.
  • Tracing OCGN's Change in Accured Expenses over 5 years: stood at $2.8 million in 2022, then slumped by 170.5% to -$1.9 million in 2023, then soared by 207.62% to $2.1 million in 2024, then slumped by 42.27% to $1.2 million in 2025, then plunged by 547.6% to -$5.4 million in 2026.
  • The last three Change in Accured Expenses figures came in at -$5.4 million (Q1 2026), $1.2 million (Q4 2025), and $3.3 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 222.50 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 492.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 11.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 55.78 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 212.44 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 61.62 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 68.82 Mn
10 Ocugen 458.91 Mn 358.81 Mn - 5.04 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.04 Mn
Mar 31, 2026 -5.40 Mn
Dec 31, 2025 1.21 Mn
Sep 30, 2025 3.29 Mn
Jun 30, 2025 2.08 Mn
Mar 31, 2025 -3.27 Mn
Dec 31, 2024 2.09 Mn
Sep 30, 2024 2.16 Mn
Jun 30, 2024 1.33 Mn
Mar 31, 2024 -1.45 Mn
Dec 31, 2023 -1.94 Mn
Sep 30, 2023 -1.35 Mn
Jun 30, 2023 -4.09 Mn
Mar 31, 2023 -4.96 Mn
Dec 31, 2022 2.75 Mn
Sep 30, 2022 3.89 Mn
Jun 30, 2022 2.71 Mn
Mar 31, 2022 131,000.00
Dec 31, 2021 573,000.00
Sep 30, 2021 1.44 Mn